Medulloblastoma (MB) is the most common pediatric brain tumour and usually affects children and infants under 10 years old. Current treatment for MB involves aggressive chemotherapy and radiation, which can lead to harmful long-term side effects, including cognitive impairment, endocrine disorders and an increased risk of secondary cancers later in life.
Congratulations to the BC Children’s and BC Women’s investigators who were awarded funding through the Canadian Institutes of Health Research (CIHR) Project Grant Fall 2020 competition. Our research community received around $6 million in new research grants.
BC Children’s Hospital Research Institute is pleased to congratulate the recipients of the 2018 Outstanding Achievement Awards and the 2018 BCCHR Studentships and Fellowships.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.